{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:44Z","timestamp":1791300524255,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/md.0b013e31824d9cec","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T04:32:26Z","timestamp":1330057946000},"page":"95-102","source":"Crossref","is-referenced-by-count":105,"title":["Inflammatory Myopathies With Anti-Ku Antibodies"],"prefix":"10.1097","volume":"91","author":[{"given":"Aude","family":"Rigolet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Musset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Charuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Behin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Herson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210226","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":". The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R2-4-20210226","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-4-20210226","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203308089442","article-title":". Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.","volume":"17","author":"Cavazzana","year":"2008","journal-title":"Lupus"},{"key":"R4-4-20210226","first-page":"563","article-title":". Clinical and serological associations of anti-Ku antibody.","volume":"26","author":"Cooley","year":"1999","journal-title":"J Rheumatol"},{"key":"R5-4-20210226","first-page":"1393","article-title":". Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.","volume":"29","author":"Franceschini","year":"2002","journal-title":"J Rheumatol"},{"key":"R6-4-20210226","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.4049\/jimmunol.136.5.1648","article-title":". Identification of Ki (Ku, p70p80) autoantigens and analysis of anti-Ki autoantibody reactivity.","volume":"136","author":"Francoeur","year":"1986","journal-title":"J Immunol"},{"key":"R7-4-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":". Clinical implications of autoantibody screening in patients with autoimmune myositis.","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"key":"R8-4-20210226","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":". Inclusion body myositis and myopathies.","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"R9-4-20210226","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":". Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies.","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R10-4-20210226","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":". Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R11-4-20210226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1269\/jrr.43.223","article-title":"Dimerization, translocation and localization of Ku70 and Ku80 proteins.","volume":"43","author":"Koike","year":"2002","journal-title":"J Radiat Res (Tokyo)"},{"key":"R12-4-20210226","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis.","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"R13-4-20210226","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI110295","article-title":". Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.","volume":"68","author":"Mimori","year":"1981","journal-title":"J Clin Invest"},{"key":"R14-4-20210226","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"R15-4-20210226","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":". p62SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R16-4-20210226","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1084\/jem.161.1.18","article-title":"Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera.","volume":"161","author":"Reeves","year":"1985","journal-title":"J Exp Med"},{"key":"R17-4-20210226","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":". Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.","volume":"67","author":"Rozman","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R18-4-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/kem338","article-title":". Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases.","volume":"47","author":"Schild-Poulter","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R19-4-20210226","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":". Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.","volume":"55","author":"Selva-OCallaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-4-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BC20050060","article-title":". Effect of Ku proteins on IRES-mediated translation.","volume":"98","author":"Silvera","year":"2006","journal-title":"Biol Cell"},{"key":"R21-4-20210226","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":". The 1982 revised criteria for the classification of systemic lupus erythematosus.","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R22-4-20210226","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":". Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R23-4-20210226","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":". Classification criteria for Sjogrens syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R24-4-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/35088000","article-title":"Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair.","volume":"412","author":"Walker","year":"2001","journal-title":"Nature"},{"key":"R25-4-20210226","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I","article-title":". Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus.","volume":"44","author":"Wang","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R26-4-20210226","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/1529-0131(200003)43:3<689::AID-ANR27>3.0.CO;2-U","article-title":". Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.","volume":"43","author":"Yamamoto","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R27-4-20210226","first-page":"366","article-title":"Antibodies against Ku protein in sera from patients with autoimmune diseases.","volume":"76","author":"Yaneva","year":"1989","journal-title":"Clin Exp Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e31824d9cec","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:56:21Z","timestamp":1786042581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201203000-00004"}},"subtitle":["A Prognosis Dependent on Associated Lung Disease"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e31824d9cec","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}